Agenus Inc. sell kostojunior
Summary
This prediction ended on 13.05.23 with a price of €1.35. With a performance of 4.32%, the SELL prediction by kostojunior for Agenus Inc. was trending in the wrong direction This prediction was marked as speculative and is excluded from kostojunior's performance statistics.Agenus is a biotechnology company focused on developing immunotherapies to treat cancer and other diseases. The company's product pipeline includes checkpoint inhibitors, which work by blocking proteins that help cancer cells evade detection by the immune system, as well as other immunotherapies designed to stimulate the body's immune response to tumors. Agenus has collaborations with large pharmaceutical companies including Merck, Incyte, and Gilead, and is actively working on bringing its products to market through clinical trials and regulatory approval. The company is listed on the NASDAQ stock exchange under the ticker symbol AGEN.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Agenus Inc. | 4.025% | 4.025% |
iShares Core DAX® | 1.883% | 5.122% |
iShares Nasdaq 100 | 0.125% | 2.574% |
iShares Nikkei 225® | -0.201% | 4.341% |
iShares S&P 500 | 0.728% | 4.141% |
According to kostojunior what are the pros and cons of Agenus Inc. for the foreseeable future?
Pros
Cons
Comments by kostojunior for this prediction
In the thread Agenus Inc. diskutieren
In the thread Trading Agenus Inc.